LifeStance Health Group

LifeStance Health Group

LFST· Services· Fiscal year ends in December

CEO pay in FY2025Stock -4.5% in FY2025

David Bourdon is the CEO of LifeStance Health Group and was paid $6.6M in FY2025 (Dec), up 93%.

Pay$100 in the stock at the end of FY21 → $74
CEO pay is from each LifeStance Health Group proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives7

See all
  1. 1Kenneth BurdickFY2025
  2. 2David BourdonFY2025
  3. 3Ryan McGroartyFY2025
  4. 4Pablo PantaleoniFY2024
  5. 5Ryan PardoFY2025
  6. 6Ann VaranakisFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

LifeStance Health Group paid its 6 named executives $26.5M in total in FY2025 (Dec). CEO David Bourdon was paid $6.6M of that.

Name
Kenneth BurdickExecutive Chairperson; Former Chief Executive Officer
David BourdonChief Executive Officer
Ryan McGroartyChief Financial Officer and TreasurerNot disclosedNot disclosed
Ryan PardoChief Legal Officer and Secretary
Ann VaranakisChief People OfficerNot disclosed
Pablo PantaleoniFormer Chief Digital OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers11

See all

The FY2025 (Dec) proxy of LifeStance Health Group names 11 peer companies for pay. Among LifeStance Health Group and these peers, CEO pay was the lowest of 5 and total shareholder return was 4th highest of 5.

5th highest of 5in LifeStance Health Group and its pay peers, FY2025 (Dec) by CEO pay:

$6.6M$23.0M

4th highest of 5in LifeStance Health Group and its pay peers, FY2025 (Dec) by total shareholder return:

$4$210

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Robert BesslerDirector · 8 yr on the boardIndependentQuality and Compliance—Paid as an executive
  • Jeffrey RhodesDirector · 5 yr on the boardIndependentNominating and Governance (Chair)—Paid as an executive
  • Katherine WoodDirector · 5 yr on the boardIndependentCompensation (Chair)—Paid as an executive
  • Teresa DeLucaDirector · 1 yr on the boardIndependentAudit, Quality and Compliance (Chair)—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    LifeStance Health Group Chair pay fell 30% to $7.1M. The stock fell 4% in FY2025 (Dec).
    DEF 14A
  2. Pay
    LifeStance Health Group CEO pay rose 93% to $6.6M. The stock fell 4% in FY2025 (Dec).
    DEF 14A
  3. Pay
    LifeStance Health Group General counsel pay rose 34% to $2.6M. The stock fell 6% in FY2024 (Dec).
    DEF 14A
  4. Pay
    LifeStance Health Group Chair pay fell 31% to $10.2M. The stock fell 6% in FY2024 (Dec).
    DEF 14A
  5. Pay
    LifeStance Health Group Former Chief Digital Officer pay rose 29% to $2.8M. The stock fell 6% in FY2024 (Dec).
    DEF 14A
  6. Pay
    LifeStance Health Group CEO pay rose 46% to $3.4M. The stock fell 6% in FY2024 (Dec).
    DEF 14A
  7. Pay
    LifeStance Health Group President pay rose 231% to $12.4M. The stock fell 6% in FY2024 (Dec).
    DEF 14A
  8. Board
    Teresa DeLuca joined the board of LifeStance Health Group. Teresa DeLuca now sits on 2 public boards.
    3
  9. Pay
    LifeStance Health Group Chair pay fell 64% to $14.8M. The stock rose 59% in FY2023 (Dec).
    DEF 14A
  10. Pay
    LifeStance Health Group CEO pay fell 53% to $2.4M. The stock rose 59% in FY2023 (Dec).
    DEF 14A
  11. Pay
    LifeStance Health Group President pay fell 73% to $3.7M. The stock rose 59% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 22, 2026FY2025
Annual report10-KFeb 25, 2026FY2025
Proxy statementDEF 14AApr 23, 2025FY2024
Annual report10-KFeb 27, 2025FY2024
Proxy statementDEF 14AApr 23, 2024FY2023
Annual report10-KFeb 28, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data